Advanced Biomed is trading at $8.53 (up 6.6%) as the stock bounces back from last week’s sharp selloff tied to a canceled securities offering and funding concerns.
- Investors appear to be reassessing dilution and capital risk following the recent announcement.
- Broader U.S. indices are trading higher, providing a more supportive backdrop for beaten-down small-cap equities.